Sunday

GIL VAN BOKKELEN

CEO; Athersys Inc., Cleveland

Age: 51
Type of organization: Biopharmaceuticals
Involvement: Chairman, Alliance for Regenerative Medicine; chairman, National Center for Regenerative Medicine; Ohio Mathematics and Science Education Policy Advisory Council
In the news: Earlier this year, Athersys Inc., which specializes in adult stem cell therapy, said it would raise $9 million in private placement financing through a stock offering. Additionally this year, the company received $3.6 million in grants to advance its MultiStem
regenerative medicine product and cell therapy platform.